작성일: 24-07-11 04:25
작성일
작성자
성함(회사명):
Felipa Tejeda
대략적인 공연예산: 
ADHD Medication During Pregnancy and Breastfeeding
The decision to stop or continue ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There isn't much information on how long-term exposure to these medications can affect the foetus.
A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medications need to balance the advantages of taking them against potential risks to the fetus. Physicians don't have the data needed to give clear guidelines however they can provide information about benefits and risks that can assist pregnant women in making informed choices.
A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate case classification and to limit the chance of bias.
The research conducted by the researchers was not without its limitations. The researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the small associations observed among the exposed groups were due to the use of medication or confounded by co-morbidities. In addition the researchers did not look at the long-term outcomes of offspring.
The study did show that infants whose mothers had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.
The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve coping skills that can lessen the impact of her disorder on her daily life and relationships.
Medication Interactions
As more women than ever before are being diagnosed with ADHD and treated with medication, the question of whether to keep or discontinue treatment during pregnancy is one that more and more physicians have to face. These decisions are often made without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge in conjunction with the experiences of other physicians and the research on the subject.
Particularly, the subject of possible risks to the baby can be a challenge. A lot of studies on this topic are based on observational evidence rather than controlled research, and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which could undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these issues by analyzing data on live and deceased births.
The conclusion The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no such relationship and the majority of studies demonstrate a neutral or slightly negative impact. In every case an in-depth analysis of the risks and benefits must be performed.
For a lot of women with ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication uk for adults medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could also impact the ability to safely drive and to perform work-related tasks which are crucial aspects of everyday life for those with ADHD.
She recommends women who are unsure about whether to keep or stop taking medication because of their pregnancy should consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. In addition, educating them can help the woman feel supported in her struggle with her decision. Certain medications can be passed through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the infant.
Birth Defects and Risk of
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. With two massive data sets researchers were able examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects such as ventriculo-septal defect (VSD).
The researchers of the study didn't find any association between early medication usage and congenital anomalies like facial deformities, or club feet. The findings are in line with previous studies showing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. This risk increased in the latter half of pregnancy, as many women are forced to stop taking their ADHD medications.
Women who took ADHD medication in the first trimester were more likely require a caesarean delivery and also have an insufficient Apgar after delivery and have a baby that needed help breathing after birth. The authors of the study were unable to remove bias in selection since they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.
The researchers hope their study will serve to inform the clinical decisions of physicians who treat pregnant women. They suggest that although the discussion of the risks and benefits is crucial however, the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.
The authors also caution that even though stopping the medication is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health problems in women who are pregnant or who are recently postpartum. Research has also shown that women who stop taking their medications will have a difficult adjustment to life without them once the baby is born.
Nursing
It can be a stressful experience becoming a mother. Women with ADHD can face severe challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women choose to continue taking their ADHD medication during pregnancy.
The risk to a nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. The rate of exposure to medication will vary based on the dosage, frequency of administration and the time of the day. In addition, various drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely known.
Because of the lack of research, some doctors might be tempted to stop taking stimulant medication during the course of pregnancy. This is a complicated decision for the patient, who must balance the benefit of continuing her medication against the possible dangers to the fetus. As long as more information is available, doctors can ask pregnant patients if they have any history of ADHD or if they intend to take medication in the perinatal phase.
Numerous studies have demonstrated that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do this. They have concluded after consulting with their doctors, that the benefits of keeping their current medication outweigh any risk.
Women with ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.
ADHD Medication During Pregnancy and BreastfeedingThe decision to stop or continue ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There isn't much information on how long-term exposure to these medications can affect the foetus.
A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medications need to balance the advantages of taking them against potential risks to the fetus. Physicians don't have the data needed to give clear guidelines however they can provide information about benefits and risks that can assist pregnant women in making informed choices.
A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based case-control study to assess the risk of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate case classification and to limit the chance of bias.
The research conducted by the researchers was not without its limitations. The researchers were unable, in the first place to differentiate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the small associations observed among the exposed groups were due to the use of medication or confounded by co-morbidities. In addition the researchers did not look at the long-term outcomes of offspring.
The study did show that infants whose mothers had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.
The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve coping skills that can lessen the impact of her disorder on her daily life and relationships.
Medication Interactions
As more women than ever before are being diagnosed with ADHD and treated with medication, the question of whether to keep or discontinue treatment during pregnancy is one that more and more physicians have to face. These decisions are often made without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge in conjunction with the experiences of other physicians and the research on the subject.
Particularly, the subject of possible risks to the baby can be a challenge. A lot of studies on this topic are based on observational evidence rather than controlled research, and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which could undervalue the serious teratogenic effects that can lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these issues by analyzing data on live and deceased births.
The conclusion The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no such relationship and the majority of studies demonstrate a neutral or slightly negative impact. In every case an in-depth analysis of the risks and benefits must be performed.
For a lot of women with ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication uk for adults medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could also impact the ability to safely drive and to perform work-related tasks which are crucial aspects of everyday life for those with ADHD.
She recommends women who are unsure about whether to keep or stop taking medication because of their pregnancy should consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. In addition, educating them can help the woman feel supported in her struggle with her decision. Certain medications can be passed through the placenta. If the patient decides to stop taking her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the infant.
Birth Defects and Risk of
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. With two massive data sets researchers were able examine more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with a slightly higher rate of certain heart defects such as ventriculo-septal defect (VSD).
The researchers of the study didn't find any association between early medication usage and congenital anomalies like facial deformities, or club feet. The findings are in line with previous studies showing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. This risk increased in the latter half of pregnancy, as many women are forced to stop taking their ADHD medications.
Women who took ADHD medication in the first trimester were more likely require a caesarean delivery and also have an insufficient Apgar after delivery and have a baby that needed help breathing after birth. The authors of the study were unable to remove bias in selection since they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.
The researchers hope their study will serve to inform the clinical decisions of physicians who treat pregnant women. They suggest that although the discussion of the risks and benefits is crucial however, the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.
The authors also caution that even though stopping the medication is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health problems in women who are pregnant or who are recently postpartum. Research has also shown that women who stop taking their medications will have a difficult adjustment to life without them once the baby is born.
Nursing
It can be a stressful experience becoming a mother. Women with ADHD can face severe challenges when they must manage their symptoms, attend doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women choose to continue taking their ADHD medication during pregnancy.
The risk to a nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. The rate of exposure to medication will vary based on the dosage, frequency of administration and the time of the day. In addition, various drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely known.
Because of the lack of research, some doctors might be tempted to stop taking stimulant medication during the course of pregnancy. This is a complicated decision for the patient, who must balance the benefit of continuing her medication against the possible dangers to the fetus. As long as more information is available, doctors can ask pregnant patients if they have any history of ADHD or if they intend to take medication in the perinatal phase.
Numerous studies have demonstrated that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. In response, a rising number of patients are opting to do this. They have concluded after consulting with their doctors, that the benefits of keeping their current medication outweigh any risk.
Women with ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and the underlying disorder. They should also learn about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatry. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration, and when necessary, making adjustments to the medication regimen.
이벤트 진행에 필요하신 사항 체크
추가사항 작성
공연팀에 대한 한줄 소개*
JE공연팀 활동 경력*
공연 자료를 확인 할 수 있는 URL 첨부해주세요*
- 이전글An Israeli missile worsens the adversity of five disabled siblings 24.07.11
- 다음글The Reasons To Work On This ADHD Medication 24.07.11
댓글목록
등록된 댓글이 없습니다.